A detailed history of Vanguard Group Inc transactions in A Ikido Pharma Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 193,392 shares of AIKI stock, worth $734,889. This represents 0.0% of its overall portfolio holdings.

Number of Shares
193,392
Previous 193,392 -0.0%
Holding current value
$734,889
Previous $734,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
N/A
100 Added 0.05%
193,392 $734,000
Q3 2023

Nov 14, 2023

SELL
N/A
-349 Reduced 0.18%
193,292 $734,000
Q4 2022

Feb 10, 2023

BUY
$3.07 - $7.21 $300 - $706
98 Added 0.05%
193,641 $635,000
Q3 2022

Nov 14, 2022

SELL
$5.6 - $7.03 $127,002 - $159,433
-22,679 Reduced 10.49%
193,543 $1.32 Million
Q2 2022

Aug 12, 2022

BUY
$4.59 - $7.99 $992,458 - $1.73 Million
216,222 New
216,222 $1.28 Million

Others Institutions Holding AIKI

About AIkido Pharma Inc.


  • Ticker AIKI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,485,100
  • Market Cap $20.8M
  • Description
  • AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...
More about AIKI
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.